Artificial intelligence is fundamentally changing how software is built. It is moving beyond just speeding up tasks. AI is ...
DatafuelX rehired co-founder Dan Aversano to take the helm as CEO and lead it through its next growth phase, which revolves ...
Celonis' Christoph Schettler declares that the era of reactive supply chains is over. As geopolitical disruptions in critical ...
The multiple condition (MC)-retention model is an uncertainty-aware graph-based neural network that predicts liquid chromatography (LC) retention times across multiple column chem ...
The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...
Phan Hoang Lam, a gifted math student from Hanoi, has secured admission to leading US universities, driven by a vision to ...
New research outlines how rising acquisition costs, creator ecosystems, and retention strategies are reshaping digital marketing across ...
As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.
A global survey of more than 100 COOs at manufacturers with revenues of more than $1 billion found that 93% plan to increase investment in AI and digital technologies over the next five years. The ...
Muse Spark is Meta’s new multimodal reasoning model built for Meta AI. Here is a clear analysis of its capabilities, ...
As artificial intelligence rapidly expands across industries, a new question is emerging: how much energy will it consume, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results